Toes-Zoutendijk Esther, de Jonge Lucie, Breekveldt Emilie C H, Korfage Ida J, Usher-Smith Juliet A, Lansdorp-Vogelaar Iris, Dennison Rebecca A
Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Prev Med Rep. 2023 Jul 16;35:102325. doi: 10.1016/j.pmedr.2023.102325. eCollection 2023 Oct.
Prior faecal Hemoglobin (f-Hb) concentrations of a negative fecal immunochemical test (FIT) can be used for risk stratification in colorectal cancer (CRC) screening. Individuals with higher f-Hb concentrations may benefit from a shorter screening interval (1 year), whereas individuals with undetectable f-Hb concentrations could benefit from a longer screening interval (3 year). Individuals' views on personalised CRC screening and information needed to make a well-informed decision is unknown. We conducted three semi-structured focus groups among individuals eligible for CRC screening (i.e. men and women aged 55 to 75) in the Netherlands. Thematic analysis was used to analyse participants' information need on personalised CRC screening strategies. Fourteen individuals took part. The majority were positive about CRC screening and indicated that they would participate in personalised CRC screening. The rationale for a longer interval among those at lowest risk was, however, unclear for many. The preferred information on individual risk was variable: ranging from full information to only information on the personalised strategy without mentioning the risk. It was not possible to address everyone's need with a single approach. Additional communications, e.g. public media campaigns, billboards, videos on social media, were also suggested as necessary. This study showed that preferences on receiving information on individual CRC risk varied substantially and no consensus was reached. Introducing a personalised screening programme will require careful communication, particularly around the rationale for the strategy, and a layered approach to deliver information.
粪便免疫化学检测(FIT)结果为阴性之前的粪便血红蛋白(f-Hb)浓度可用于结直肠癌(CRC)筛查的风险分层。f-Hb浓度较高的个体可能受益于较短的筛查间隔(1年),而f-Hb浓度检测不到的个体可能受益于较长的筛查间隔(3年)。个体对个性化CRC筛查的看法以及做出明智决策所需的信息尚不清楚。我们在荷兰对符合CRC筛查条件的个体(即55至75岁的男性和女性)进行了三个半结构化焦点小组访谈。采用主题分析法分析参与者对个性化CRC筛查策略的信息需求。14人参与了访谈。大多数人对CRC筛查持积极态度,并表示他们会参与个性化CRC筛查。然而,许多人不清楚风险最低的人群筛查间隔较长的理由。关于个体风险的首选信息各不相同:从完整信息到仅关于个性化策略的信息,而不提及风险。单一方法无法满足每个人的需求。还建议必要时进行额外的宣传,如公共媒体宣传活动、广告牌、社交媒体视频等。这项研究表明,个体对CRC风险信息的接受偏好差异很大,未达成共识。引入个性化筛查计划需要谨慎沟通,特别是围绕策略的基本原理,并采用分层方法来提供信息。